vs
Side-by-side financial comparison of BLACKLINE, INC. (BL) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $183.2M, roughly 1.9× BLACKLINE, INC.). HAEMONETICS CORP runs the higher net margin — 13.2% vs 2.7%, a 10.5% gap on every dollar of revenue. On growth, BLACKLINE, INC. posted the faster year-over-year revenue change (8.1% vs -2.7%). HAEMONETICS CORP produced more free cash flow last quarter ($87.2M vs $26.1M). Over the past eight quarters, BLACKLINE, INC.'s revenue compounded faster (7.9% CAGR vs 0.4%).
BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
BL vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $183.2M | $339.0M |
| Net Profit | $4.9M | $44.7M |
| Gross Margin | 75.2% | 59.7% |
| Operating Margin | 3.7% | 19.9% |
| Net Margin | 2.7% | 13.2% |
| Revenue YoY | 8.1% | -2.7% |
| Net Profit YoY | -91.3% | 19.3% |
| EPS (diluted) | $0.07 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.2M | $339.0M | ||
| Q3 25 | $178.3M | $327.3M | ||
| Q2 25 | $172.0M | $321.4M | ||
| Q1 25 | $166.9M | $330.6M | ||
| Q4 24 | $169.5M | $348.5M | ||
| Q3 24 | $165.9M | $345.5M | ||
| Q2 24 | $160.5M | $336.2M | ||
| Q1 24 | $157.5M | — |
| Q4 25 | $4.9M | $44.7M | ||
| Q3 25 | $5.3M | $38.7M | ||
| Q2 25 | $8.3M | $34.0M | ||
| Q1 25 | $6.1M | $58.0M | ||
| Q4 24 | $56.4M | $37.5M | ||
| Q3 24 | $17.2M | $33.8M | ||
| Q2 24 | $76.7M | $38.4M | ||
| Q1 24 | $10.8M | — |
| Q4 25 | 75.2% | 59.7% | ||
| Q3 25 | 75.1% | 59.5% | ||
| Q2 25 | 75.2% | 59.8% | ||
| Q1 25 | 75.5% | 58.4% | ||
| Q4 24 | 75.6% | 55.5% | ||
| Q3 24 | 75.2% | 54.2% | ||
| Q2 24 | 74.9% | 52.0% | ||
| Q1 24 | 75.2% | — |
| Q4 25 | 3.7% | 19.9% | ||
| Q3 25 | 4.3% | 17.9% | ||
| Q2 25 | 4.4% | 16.8% | ||
| Q1 25 | 2.1% | 21.6% | ||
| Q4 24 | 3.7% | 16.9% | ||
| Q3 24 | 5.0% | 15.0% | ||
| Q2 24 | 1.4% | 11.8% | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 2.7% | 13.2% | ||
| Q3 25 | 3.0% | 11.8% | ||
| Q2 25 | 4.8% | 10.6% | ||
| Q1 25 | 3.6% | 17.5% | ||
| Q4 24 | 33.3% | 10.8% | ||
| Q3 24 | 10.4% | 9.8% | ||
| Q2 24 | 47.8% | 11.4% | ||
| Q1 24 | 6.9% | — |
| Q4 25 | $0.07 | $0.95 | ||
| Q3 25 | $0.09 | $0.81 | ||
| Q2 25 | $0.13 | $0.70 | ||
| Q1 25 | $0.10 | $1.17 | ||
| Q4 24 | $0.79 | $0.74 | ||
| Q3 24 | $0.27 | $0.66 | ||
| Q2 24 | $0.22 | $0.74 | ||
| Q1 24 | $0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $390.0M | $363.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $332.3M | $911.5M |
| Total Assets | $1.8B | $2.5B |
| Debt / EquityLower = less leverage | — | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $390.0M | $363.4M | ||
| Q3 25 | $419.9M | $296.4M | ||
| Q2 25 | $459.1M | $292.9M | ||
| Q1 25 | $479.5M | $306.8M | ||
| Q4 24 | $885.9M | $320.8M | ||
| Q3 24 | $725.3M | $299.3M | ||
| Q2 24 | $616.6M | $344.4M | ||
| Q1 24 | $331.4M | — |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $332.3M | $911.5M | ||
| Q3 25 | $328.3M | $849.2M | ||
| Q2 25 | $414.0M | $882.3M | ||
| Q1 25 | $417.9M | $820.8M | ||
| Q4 24 | $446.7M | $906.9M | ||
| Q3 24 | $367.9M | $878.9M | ||
| Q2 24 | $325.8M | $905.4M | ||
| Q1 24 | $279.8M | — |
| Q4 25 | $1.8B | $2.5B | ||
| Q3 25 | $1.7B | $2.4B | ||
| Q2 25 | $1.8B | $2.5B | ||
| Q1 25 | $1.8B | $2.5B | ||
| Q4 24 | $1.8B | $2.5B | ||
| Q3 24 | $1.7B | $2.5B | ||
| Q2 24 | $1.9B | $2.5B | ||
| Q1 24 | $2.1B | — |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.7M | $93.6M |
| Free Cash FlowOCF − Capex | $26.1M | $87.2M |
| FCF MarginFCF / Revenue | 14.2% | 25.7% |
| Capex IntensityCapex / Revenue | 0.3% | 1.9% |
| Cash ConversionOCF / Net Profit | 5.46× | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $161.5M | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.7M | $93.6M | ||
| Q3 25 | $63.8M | $111.3M | ||
| Q2 25 | $32.3M | $17.4M | ||
| Q1 25 | $46.7M | $116.6M | ||
| Q4 24 | $43.8M | $43.8M | ||
| Q3 24 | $55.9M | $48.8M | ||
| Q2 24 | $40.7M | $-27.4M | ||
| Q1 24 | $50.4M | — |
| Q4 25 | $26.1M | $87.2M | ||
| Q3 25 | $63.3M | $106.3M | ||
| Q2 25 | $31.4M | $13.6M | ||
| Q1 25 | $40.8M | $100.9M | ||
| Q4 24 | $43.0M | $35.2M | ||
| Q3 24 | $55.5M | $39.4M | ||
| Q2 24 | $40.0M | $-33.1M | ||
| Q1 24 | $50.1M | — |
| Q4 25 | 14.2% | 25.7% | ||
| Q3 25 | 35.5% | 32.5% | ||
| Q2 25 | 18.2% | 4.2% | ||
| Q1 25 | 24.4% | 30.5% | ||
| Q4 24 | 25.4% | 10.1% | ||
| Q3 24 | 33.5% | 11.4% | ||
| Q2 24 | 24.9% | -9.8% | ||
| Q1 24 | 31.8% | — |
| Q4 25 | 0.3% | 1.9% | ||
| Q3 25 | 0.3% | 1.5% | ||
| Q2 25 | 0.6% | 1.2% | ||
| Q1 25 | 3.6% | 4.7% | ||
| Q4 24 | 0.4% | 2.5% | ||
| Q3 24 | 0.2% | 2.7% | ||
| Q2 24 | 0.4% | 1.7% | ||
| Q1 24 | 0.2% | — |
| Q4 25 | 5.46× | 2.09× | ||
| Q3 25 | 12.07× | 2.88× | ||
| Q2 25 | 3.90× | 0.51× | ||
| Q1 25 | 7.72× | 2.01× | ||
| Q4 24 | 0.78× | 1.17× | ||
| Q3 24 | 3.24× | 1.44× | ||
| Q2 24 | 0.53× | -0.71× | ||
| Q1 24 | 4.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
